Merck

Merck & Co., Inc. NYSE: MRK or Merck Sharp and Dohme (as it is known outside the USA and Canada) is a US pharmaceutical company. It was originally the US subsidiary of the German company, Merck KGaA. In common with many other German assets in the United States, Merck & Co. was confiscated in 1917 during First World War and set up as an independent company. It is now one of the top 5 largest pharmaceutical companies in the world both by capital and revenue.

History
Merck & Co. traces its origins to Friedrich Jacob Merck (1668) and Emanuel Merck (1816) of Darmstadt, Hesse. Emanuel and his successors gradually built up a chemical-pharmaceutical factory that produced — in addition to raw materials for pharmaceutical preparations — a multitude of other chemicals.

In 1891, George Merck established his roots in the United States and set up Merck & Co. in New York, USA. Merck & Co. was confiscated in 1917 during First World War and set up as an independent company in the United States. Today, the US company has about 70,000 employees in 120 countries and 31 factories worldwide. It is one of the top 5 pharmaceutical companies worldwide, much larger than its German ancestor, which currently employees around 28,600 people in 54 countries.

In 2005, the CEO, Raymond Gilmartin, retired at the age of 64 following the Vioxx scandal. Former president of manufacturing Richard Clark was named CEO of the company.

Mission
Merck & Co. or MSD describes itself as a “a global research-driven pharmaceutical company. Merck discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures.” Its mission is “to provide society with superior products and services by developing innovations and solutions that improve the quality of life and satisfy customer needs, and to provide employees with meaningful work and advancement opportunities, and investors with a superior rate of return.

Merck also states that it prides itself on its commitment to diversity and its social conscience. The Merck Company Foundation has distributed over $160 million to educational and non-profit organizations since it was founded in 1957.

Merck has published the Merck Manual of Medical Information since 1899, which has been used by doctors and families alike.

Merck is also famous for publishing their Merck Index, an authoritative collection of information about chemicals.

Products
Vytorin (ezetimibe;simvastatin)
Zocor (simvastatin)
Propecia (finasteride)
Emend (aprepitant)
Fosamax (alendronate)
Singulair (montelukast)
Crixivan (indavinir)
Maxalt (rizatriptan)
Zetia (ezetimibe)

Vioxx
In 1999, the United States Food and Drug Administration ("FDA") approved Vioxx (known generically as rofecoxib,) a Merck product that became widely used for treating arthritis. Thereafter, studies by Merck and by others found an increased risk of heart attack associated with Vioxx use when compared with Naproxen (an established drug used for treating arthritis). The position of Merck at the time was that there was no indication of this risk in the original placebo-controlled safety trials, and that it was possible that the effect was more related to Naproxen decreasing the risk of heart attacks than one of Vioxx increasing the risk. There was significant controversy over the matter since such an effect had not been previously observed with Naproxen.

On September 23, 2004, Merck received information about results from a clinical it was conducting that supported previous findings of increased risk of heart attack among Vioxx users. [1] On September 28, Merck notified the FDA that it was withdrawing Vioxx from the market, and it publicly announced the withdrawal on September 30.

On November 5 the medical journal The Lancet published the results of its analysis of the available studies. It concluded that “the unacceptable cardiovascular risks of Vioxx (rofecoxib) were evident as early as 2000...” [2] The Lancet condemned Merck for having kept the drug on the market, despite its knowledge of the risks, and also criticized the FDA for its failure of regulatory oversight.

On August 19, 2005, Merck was found liable in the death of a man who took Vioxx. A jury in Angleton, Texas reached the verdict after deliberating for 10 1/2 hours. Jurors voted 10-2 in favor of the plaintiff Carol Ernst, the widow of the deceased man. Ernst was awarded $253.4 million in damages. The fact that Merck apparently kept Vioxx on the market knowing its potential risks weighed heavily on the case. In addition, at the time of the verdict, there were over 4,000 other lawsuits pending against Merck regarding Vioxx. A trial is set to begin in New Jersey (where Merck is based) in September 2005 and another case is set to begin in New Orleans, Louisiana in late November 2005. Merck's stock fell $2.35 to $28.06/share (7.73%) in the minutes after the verdict was announced.

Merck is currently trying to get a successor drug to Vioxx, called Arcoxia (known generically as etoricoxib) approved in the USA. The FDA has said it will approve Arcoxia if it proves to be safer than Vioxx. Two other drug companies, Pfizer and Novartis, are trying to get alternatives to Vioxx approved. Their drugs are called Dynastat (parecoxib) and Prexige (lumiracoxib), respectively.

Diversity
Merck & Co. was named one of the 100 Best Companies for Working Mothers in 2004 by Working Mothers magazine.

Merck & Co., history Inc. NYSE: MRK or Merck Sharp and merck Dohme (
as vioxx it is known outside the USA program and Canada) is a US pharmaceutical company. It was originally the US merck subsidiary of the German company, Merck KGaA. In common with plant many other German assets merck in representatives the United States, Merck and
& Co. was
confiscated in merck 1917 team merck during First World War and set up ethanol assistance packaging as an independent pennsylvania company. It is now one of fda the top 5 pennsylvania ohio largest merck pharmaceutical companies in the world both by
merck capital and revenue.

merck vioxx recall

History
Merck
& merck Co. traces its vioxx origins company to
Friedrich Jacob Merck (1668) and Emanuel frosst Merck (merck 1816) merck of Darmstadt, Hesse. Emanuel and
his
successors gradually marketing built up
a chemical-pharmaceutical merck factory that produced —

of in addition to raw philadelphia
materials for pharmaceutical
preparations — merck a multitude of other chemicals.

In 1891, George vet
Merck established his roots in the United States and melinda merck set up Merck & Co. in New York, USA. Merck & philadelphia Co. was confiscated in 1917 merck during First merck merck merck World War and set up as an merck independent company in the recall United States. Today, the US company has about 70,000 employees in 120 countries edition and medco 31 factories
worldwide. It multinational company is one of the top vioxx 5 pharmaceutical companies worldwide, much larger than its German ancestor, which currently employees around 28,merck 600 people in 54 countries.

logo In 2005, the merck CEO, Raymond Gilmartin, retired at the age of 64 following the merck Vioxx scandal. Former merck
president of manufacturing Richard Clark was named CEO of the company.

Mission
Merck
news and & Co. or MSD jersey describes itself as a “a donation global research-vet founded driven profile pharmaceutical merck company. Merck home discovers,
develops, manufactures and markets a broad range of refill
innovative products to improve services human and animal analysis program health, medco directly and through its merck joint ventures.” Its mission is sciences
“to provide hpv society with merck superior products and services by developing innovations and solutions credit that medico analysis improve the vioxx quality of life and satisfy customer needs, and to merck merck provide merck employees with meaningful work and history advancement opportunities,
and investors merck
with a rx pharmaceutical superior rate of merck return.

vioxx Merck also states that marketing blood it prides itself on its commitment to mectizan diversity and its social conscience. The trials Merck merck Company Foundation has distributed over $160 merck million to educational and
non-profit organizations since it was founded in 1957.

Merck has published the Merck Manual of Medical Information since 1899, which mercuriadis has been manual on used by doctors
pennsylvania and families alike.

Merck manual is also famous for publishing their Merck Index,
an authoritative merck collection of and information

about chemicals.

Products
Vytorin (ezetimibe;simvastatin)
merck Zocor (simvastatin)
Propecia (vaccine
finasteride)
Emend (aprepitant)
Fosamax (alendronate)
Singulair ( montelukast)
history Crixivan (merck indavinir)
Maxalt (merck rizatriptan)
Zetia (ezetimibe)

Vioxx
In
1999, the United States Food and
Drug Administration ("FDA") approved Vioxx ( known
alan generically as rofecoxib,)
a Merck hevesi product merck of that old became widely used new for treating arthritis. Thereafter, studies merck by Merck
and by others found an increased risk of heart attack merck associated with
philadelphia
Vioxx use when compared pressure with Naproxen (
an established
drug used for treating arthritis). The position of Merck at the
time was
that there merck
was no indication of this risk new in the original placebo-pharmaceuticals merck controlled co. safety trials, and that it merck
was possible that
the effect was more related to of Naproxen decreasing the risk of heart attacks than one of Vioxx increasing
the + risk.
There pennsylvania was
significant merck merck controversy over the profile matter merck since such merck life an effect river medco had not been absolute previously observed with vioxxsecrets.com Naproxen.

On merck September news
23, 2004, drugs
merck george Merck received information about pharmaceutical results from a clinical merck it was conducting that supported previous findings of increased risk of heart attack among Vioxx users. [1] On September 28, Merck notified union the merck FDA
marketing that it was withdrawing medco Vioxx from the market, and it publicly announced the withdrawal on September 30.

On November 5 the medical journal supplies The Lancet published company the results index vioxx of its analysis
of
the available merck studies. It concluded that “the unacceptable cardiovascular risks vioxx of Vioxx (rofecoxib) were evident rx as early as 2000...” [2] The Lancet condemned merck Merck for
having and merck kept the online drug on the market, despite its knowledge medco of philadelphia the
risks, integra
and also criticized dvm the FDA merck for its
history failure of new regulatory oversight.

On August inc. 19, 2005, Merck was found clinical liable in the death of a philadelphia man who took Vioxx. A jury in Angleton, Texas reached the verdict after deliberating
and for
strategy 10 1/2 merck hours. Jurors voted 10-2 in high favor of the plaintiff Carol Ernst, the widow of the company deceased india pharmacy man. Ernst was awarded $253.4 jersey million in damages. The fact that Merck apparently
kept relationship Vioxx on the market
knowing its potential risks weighed pennsylvania heavily on the case.
In addition, vioxx at the time of the verdict, merck there the were over 4, 000 merck per paid and other lawsuits pending against Merck regarding prescription Vioxx. A trial
is set york to begin flint in merck New Jersey (where
Merck is based) in discount September 2005 and another case history is set to begin in New Orleans, Louisiana in late November
merck 2005. Merck's stock fell $2. 35 jobs to pharmaceutical $28.06/share (7.73%) in the minutes merck after christmas the verdict was announced.

merck Merck is currently trying to get a successor drug sec to Vioxx, merck called Arcoxia (merck known generically analysis as etoricoxib) approved in the USA.
The FDA has said it will approve Arcoxia if it kgaa proves patient to be safer than Vioxx. bioreactor
world Two other drug companies, Pfizer
percription and Novartis, are prescriptions trying to get alternatives chemicals to Vioxx approved. Their drugs are called Dynastat (parecoxib) and Prexige (lumiracoxib), respectively.

Diversity
and Merck & Co. was named one of medical the 100 Best Companies for merck Working Mothers in 2004 drug by vaccine Working Mothers merck magazine.

Information provided by Wikipedia.